Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Coombes NS"'
Autor:
Feng, S, Phillips, DJ, White, T, Sayal, H, Aley, PK, Bibi, S, Dold, C, Fuskova, M, Gilbert, SC, Hirsch, I, Humphries, HE, Jepson, B, Kelly, EJ, Plested, E, Shoemaker, K, Thomas, KM, Vekemans, J, Villafana, TL, Lambe, T, Pollard, AJ, Voysey, M, Adlou, S, Allen, L, Angus, B, Anslow, R, Asselin, M-C, Baker, N, Baker, P, Barlow, T, Beveridge, A, Bewley, KR, Brown, P, Brunt, E, Buttigieg, KR, Camara, S, Charlton, S, Chiplin, E, Cicconi, P, Clutterbuck, EA, Collins, AM, Coombes, NS, Clemens, SAC, Davison, M, Demissie, T, Dinesh, T, Douglas, AD, Duncan, CJA, Emary, KRW, Ewer, KJ, Felle, S, Ferreira, DM, Finn, A, Folegatti, PM, Fothergill, R, Fraser, S, Garlant, H, Gatcombe, L, Godwin, KJ, Goodman, AL, Green, CA, Hallis, B, Hart, TC, Heath, PT, Hill, H, Hill, AVS, Jenkin, D, Kasanyinga, M, Kerridge, S, Knight, C, Leung, S, Libri, V, Lillie, PJ, Marinou, S, McGlashan, J, McGregor, AC, McInroy, L, Minassian, AM, Mujadidi, YF, Penn, EJ, Petropoulos, CJ, Pollock, KM, Proud, PC, Provstgaard-Morys, S, Rajapaska, D, Ramasamy, MN, Sanders, K, Shaik, I, Singh, N, Smith, A, Snape, MD, Song, R, Shrestha, S, Sutherland, RK, Thomson, EC, Turner, DPJ, Webb-Bridges, A, Wrin, T, Williams, CJ
Publikováno v:
Nature Medicine
The global supply of COVID-19 vaccines remains limited. An understanding of the immune response that is predictive of protection could facilitate rapid licensure of new vaccines. Data from a randomized efficacy trial of the ChAdOx1 nCoV-19 (AZD1222)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb4f2fd5f45e6c2c0e1c1d6865f6d232
https://pubmed.ncbi.nlm.nih.gov/34588689
https://pubmed.ncbi.nlm.nih.gov/34588689
Autor:
Bown A; Diagnostic Evaluation and Innovation Group, Diagnostics and Pathogen Characterisation Division, UK Health Security Agency, Porton Down, UK. Electronic address: abbie.bown@ukhsa.gov.uk., Sweed A; Diagnostic Evaluation and Innovation Group, Diagnostics and Pathogen Characterisation Division, UK Health Security Agency, Porton Down, UK., Catton M; Diagnostic Evaluation and Innovation Group, Diagnostics and Pathogen Characterisation Division, UK Health Security Agency, Porton Down, UK., Nelthorpe-Cowne J; Diagnostic Evaluation and Innovation Group, Diagnostics and Pathogen Characterisation Division, UK Health Security Agency, Porton Down, UK., Conti-Frith H; Diagnostic Evaluation and Innovation Group, Diagnostics and Pathogen Characterisation Division, UK Health Security Agency, Porton Down, UK., Elderfield R; Diagnostic Evaluation and Innovation Group, Diagnostics and Pathogen Characterisation Division, UK Health Security Agency, Porton Down, UK., Terrey J; Diagnostic Evaluation and Innovation Group, Diagnostics and Pathogen Characterisation Division, UK Health Security Agency, Porton Down, UK., Abib H; Diagnostic Evaluation and Innovation Group, Diagnostics and Pathogen Characterisation Division, UK Health Security Agency, Porton Down, UK., Lui C; Diagnostic Evaluation and Innovation Group, Diagnostics and Pathogen Characterisation Division, UK Health Security Agency, Porton Down, UK., Fisher E; Diagnostic Evaluation and Innovation Group, Diagnostics and Pathogen Characterisation Division, UK Health Security Agency, Porton Down, UK., Bewley KR; Vaccine Development and Evaluation Preparedness Division, UK Health Security Agency, Porton Down, UK., Coombes NS; Vaccine Development and Evaluation Preparedness Division, UK Health Security Agency, Porton Down, UK., Robinson D; Product and Delivery, UK Health Security Agency, UK., Agrawal S; Product and Delivery, UK Health Security Agency, UK., Hallis B; Vaccine Development and Evaluation Preparedness Division, UK Health Security Agency, Porton Down, UK., Blandford E; Public Health and Clinical Oversight, Clinical and Public Health Division, UK Health Security Agency, UK., Fowler T; Public Health and Clinical Oversight, Clinical and Public Health Division, UK Health Security Agency, UK., Williamson DA; Specialist Microbiology and Laboratories, UK Health Security Agency, UK., Vipond R; Diagnostic Evaluation and Innovation Group, Diagnostics and Pathogen Characterisation Division, UK Health Security Agency, Porton Down, UK.
Publikováno v:
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2024 Feb; Vol. 139, pp. 168-170. Date of Electronic Publication: 2023 Dec 25.
Autor:
Davies ER; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Ryan KA; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Bewley KR; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Coombes NS; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Salguero FJ; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Carnell OT; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Biddlecombe S; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Charlton M; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Challis A; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Cross ES; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Handley A; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Ngabo D; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Weldon TM; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Hall Y; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Funnell SGP; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK.; Quadram Institute Bioscience, Norwich Research Park, Norwich NR4 7UQ, UK.; World Health Organization, Appia 20, 1211 Geneva, Switzerland.
Publikováno v:
Viruses [Viruses] 2023 May 10; Vol. 15 (5). Date of Electronic Publication: 2023 May 10.
Autor:
Ryan KA; UK Health Security Agency, Salisbury, United Kingdom., Bewley KR; UK Health Security Agency, Salisbury, United Kingdom., Watson RJ; UK Health Security Agency, Salisbury, United Kingdom., Burton C; UK Health Security Agency, Salisbury, United Kingdom., Carnell O; UK Health Security Agency, Salisbury, United Kingdom., Cavell BE; UK Health Security Agency, Salisbury, United Kingdom., Challis A; UK Health Security Agency, Salisbury, United Kingdom., Coombes NS; UK Health Security Agency, Salisbury, United Kingdom., Davies ER; UK Health Security Agency, Salisbury, United Kingdom., Edun-Huges J; UK Health Security Agency, Salisbury, United Kingdom., Emery K; UK Health Security Agency, Salisbury, United Kingdom., Fell R; UK Health Security Agency, Salisbury, United Kingdom., Fotheringham SA; UK Health Security Agency, Salisbury, United Kingdom., Gooch KE; UK Health Security Agency, Salisbury, United Kingdom., Gowan K; UK Health Security Agency, Salisbury, United Kingdom., Handley A; UK Health Security Agency, Salisbury, United Kingdom., Harris DJ; UK Health Security Agency, Salisbury, United Kingdom., Hesp R; UK Health Security Agency, Salisbury, United Kingdom., Hunter L; UK Health Security Agency, Salisbury, United Kingdom., Humphreys R; UK Health Security Agency, Salisbury, United Kingdom., Johnson R; UK Health Security Agency, Salisbury, United Kingdom., Kennard C; UK Health Security Agency, Salisbury, United Kingdom., Knott D; UK Health Security Agency, Salisbury, United Kingdom., Lister S; UK Health Security Agency, Salisbury, United Kingdom., Morley D; UK Health Security Agency, Salisbury, United Kingdom., Ngabo D; UK Health Security Agency, Salisbury, United Kingdom., Osman KL; UK Health Security Agency, Salisbury, United Kingdom., Paterson J; UK Health Security Agency, Salisbury, United Kingdom., Penn EJ; UK Health Security Agency, Salisbury, United Kingdom., Pullan ST; UK Health Security Agency, Salisbury, United Kingdom., Richards KS; UK Health Security Agency, Salisbury, United Kingdom., Summers S; UK Health Security Agency, Salisbury, United Kingdom., Thomas SR; UK Health Security Agency, Salisbury, United Kingdom., Weldon T; UK Health Security Agency, Salisbury, United Kingdom., Wiblin NR; UK Health Security Agency, Salisbury, United Kingdom., Rayner EL; UK Health Security Agency, Salisbury, United Kingdom., Vipond RT; UK Health Security Agency, Salisbury, United Kingdom., Hallis B; UK Health Security Agency, Salisbury, United Kingdom., Salguero FJ; UK Health Security Agency, Salisbury, United Kingdom., Funnell SGP; UK Health Security Agency, Salisbury, United Kingdom., Hall Y; UK Health Security Agency, Salisbury, United Kingdom.
Publikováno v:
PLoS pathogens [PLoS Pathog] 2023 Apr 04; Vol. 19 (4), pp. e1011293. Date of Electronic Publication: 2023 Apr 04 (Print Publication: 2023).
Autor:
Handley A; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Ryan KA; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Davies ER; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Bewley KR; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Carnell OT; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Challis A; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Coombes NS; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Fotheringham SA; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Gooch KE; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Charlton M; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Harris DJ; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Kennard C; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Ngabo D; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Weldon TM; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Salguero FJ; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK., Funnell SGP; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK.; Quadram Institute Bioscience, Norwich Research Park, Norwich NR4 7UQ, UK.; World Health Organization, Appia 20, 1211 Geneva, Switzerland., Hall Y; UKHSA Porton, Vaccine Development and Evaluation Centre, UK Health Security Agency, Manor Farm Road, Salisbury SP4 0JG, UK.
Publikováno v:
Viruses [Viruses] 2023 Mar 14; Vol. 15 (3). Date of Electronic Publication: 2023 Mar 14.
Autor:
Coombes NS; Medical Interventions Group, UK Health Security Agency, Porton Down, Salisbury SP4 0JG, UK., Bewley KR; Medical Interventions Group, UK Health Security Agency, Porton Down, Salisbury SP4 0JG, UK., Le Duff Y; Division of Infectious Disease Diagnostics, National Institute for Biological Standards, Medicines and Healthcare Products Regulatory Agency, Potters Bar EN6 3QG, UK., Hurley M; Division of Infectious Disease Diagnostics, National Institute for Biological Standards, Medicines and Healthcare Products Regulatory Agency, Potters Bar EN6 3QG, UK., Smith LJ; Medical Interventions Group, UK Health Security Agency, Porton Down, Salisbury SP4 0JG, UK., Weldon TM; Medical Interventions Group, UK Health Security Agency, Porton Down, Salisbury SP4 0JG, UK., Osman K; Medical Interventions Group, UK Health Security Agency, Porton Down, Salisbury SP4 0JG, UK., Pullan S; Medical Interventions Group, UK Health Security Agency, Porton Down, Salisbury SP4 0JG, UK., Berry N; Division of Infectious Disease Diagnostics, National Institute for Biological Standards, Medicines and Healthcare Products Regulatory Agency, Potters Bar EN6 3QG, UK., Hallis B; Medical Interventions Group, UK Health Security Agency, Porton Down, Salisbury SP4 0JG, UK., Charlton S; Medical Interventions Group, UK Health Security Agency, Porton Down, Salisbury SP4 0JG, UK., Hall Y; Medical Interventions Group, UK Health Security Agency, Porton Down, Salisbury SP4 0JG, UK., Funnell SGP; Medical Interventions Group, UK Health Security Agency, Porton Down, Salisbury SP4 0JG, UK.
Publikováno v:
Viruses [Viruses] 2023 Feb 25; Vol. 15 (3). Date of Electronic Publication: 2023 Feb 25.
Autor:
Parry H; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Tut G; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Bruton R; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Faustini S; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Stephens C; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Saunders P; Clinical Lead, Quinton and Harborne PCN, Ridgacre House Surgery, Quinton, United Kingdom., Bentley C; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Hilyard K; Vaccine Taskforce, Department for Business, Energy and Industrial Strategy, London, United Kingdom., Brown K; National infection Service, Public Health England, London, United Kingdom., Amirthalingam G; National infection Service, Public Health England, London, United Kingdom., Charlton S; National infection Service, Public Health England, Porton Down, Salisbury, United Kingdom., Leung S; National infection Service, Public Health England, Porton Down, Salisbury, United Kingdom., Chiplin E; National infection Service, Public Health England, Porton Down, Salisbury, United Kingdom., Coombes NS; National infection Service, Public Health England, Porton Down, Salisbury, United Kingdom., Bewley KR; National infection Service, Public Health England, Porton Down, Salisbury, United Kingdom., Penn EJ; National infection Service, Public Health England, Porton Down, Salisbury, United Kingdom., Rowe C; National infection Service, Public Health England, Porton Down, Salisbury, United Kingdom., Otter A; National infection Service, Public Health England, Porton Down, Salisbury, United Kingdom., Watts R; National infection Service, Public Health England, Porton Down, Salisbury, United Kingdom., D'Arcangelo S; National infection Service, Public Health England, Porton Down, Salisbury, United Kingdom., Hallis B; National infection Service, Public Health England, Porton Down, Salisbury, United Kingdom., Makin A; Oxford Immunotec Ltd, Abingdon, United Kingdom., Richter A; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Zuo J; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Moss P; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
Publikováno v:
ELife [Elife] 2021 Sep 29; Vol. 10. Date of Electronic Publication: 2021 Sep 29.
Autor:
Bewley KR; National Infection Service, Public Health England, Salisbury, UK. Kevin.Bewley@phe.gov.uk., Coombes NS; National Infection Service, Public Health England, Salisbury, UK., Gagnon L; Nexelis, Laval, Quebec, Canada., McInroy L; National Infection Service, Public Health England, Salisbury, UK., Baker N; National Infection Service, Public Health England, Salisbury, UK., Shaik I; National Infection Service, Public Health England, Salisbury, UK., St-Jean JR; Nexelis, Laval, Quebec, Canada., St-Amant N; Nexelis, Laval, Quebec, Canada., Buttigieg KR; National Infection Service, Public Health England, Salisbury, UK., Humphries HE; National Infection Service, Public Health England, Salisbury, UK., Godwin KJ; National Infection Service, Public Health England, Salisbury, UK., Brunt E; National Infection Service, Public Health England, Salisbury, UK., Allen L; National Infection Service, Public Health England, Salisbury, UK., Leung S; National Infection Service, Public Health England, Salisbury, UK., Brown PJ; National Infection Service, Public Health England, Salisbury, UK., Penn EJ; National Infection Service, Public Health England, Salisbury, UK., Thomas K; National Infection Service, Public Health England, Salisbury, UK., Kulnis G; Nexelis, Laval, Quebec, Canada., Hallis B; National Infection Service, Public Health England, Salisbury, UK., Carroll M; National Infection Service, Public Health England, Salisbury, UK., Funnell S; National Infection Service, Public Health England, Salisbury, UK., Charlton S; National Infection Service, Public Health England, Salisbury, UK.
Publikováno v:
Nature protocols [Nat Protoc] 2021 Jun; Vol. 16 (6), pp. 3114-3140. Date of Electronic Publication: 2021 Apr 23.
Autor:
Salguero FJ; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., White AD; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Slack GS; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Fotheringham SA; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Bewley KR; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Gooch KE; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Longet S; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Humphries HE; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Watson RJ; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Hunter L; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Ryan KA; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Hall Y; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Sibley L; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Sarfas C; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Allen L; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Aram M; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Brunt E; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Brown P; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Buttigieg KR; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Cavell BE; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Cobb R; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Coombes NS; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Darby A; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK., Daykin-Pont O; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Elmore MJ; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Garcia-Dorival I; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK., Gkolfinos K; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Godwin KJ; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Gouriet J; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Halkerston R; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Harris DJ; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Hender T; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Ho CMK; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Kennard CL; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Knott D; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Leung S; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Lucas V; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Mabbutt A; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Morrison AL; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Nelson C; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK., Ngabo D; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Paterson J; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Penn EJ; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Pullan S; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Taylor I; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Tipton T; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Thomas S; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Tree JA; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Turner C; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Vamos E; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK., Wand N; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Wiblin NR; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Charlton S; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Dong X; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK., Hallis B; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Pearson G; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Rayner EL; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Nicholson AG; Royal Brompton and Harefield NHS Foundation Trust, and National Heart and Lung Institute, Imperial College, London, UK., Funnell SG; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Hiscox JA; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.; Infectious Diseases Horizontal Technology Centre (ID HTC), A*STAR, Singapore, Singapore., Dennis MJ; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Gleeson FV; Department of Oncology, Oxford University, Oxford, UK., Sharpe S; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK., Carroll MW; National Infection Service, Public Health England (PHE), Porton Down, Salisbury, Wiltshire, UK. miles.carroll@phe.gov.uk.; Nuffield Department of Medicine, Wellcome Trust Centre for Human Genetics, Oxford University, Oxford, OX3 7BN, UK. miles.carroll@phe.gov.uk.
Publikováno v:
Nature communications [Nat Commun] 2021 Feb 24; Vol. 12 (1), pp. 1260. Date of Electronic Publication: 2021 Feb 24.